NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & ...

The Chicago Bears appear to be losing out on the bid to land Detroit Lions offensive coordinator Ben Johnson. The Las Vegas Raiders have suddenly popped as the leader in the chase to land the ...

The grass is always greener on the other side of Steel City, and without a doubt, former Steelers WR Diontae Johnson found ...

Minority owner Tom Brady could bump into some of the Raiders' top coaching and GM candidates before his broadcast this ...

The Las Vegas Raiders are still on the hunt for their next head coach, and they may be zeroing in on their top potential ...

Brooklyn Nets forward Cam Johnson has had to step up this season after several players have left the team. Johnson's usage ...

Pharmaceutical giant Johnson & Johnson (J&J) (NYSE:JNJ) has announced plans to acquire Intra-Cellular Therapies (NASDAQ:ITCI) ...

Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...

Johnson & Johnson is set to acquire Intra-Cellular Therapies for $14.6 billion to enhance its neuroscience drug portfolio.

S&P Global Ratings placed Johnson & Johnson on CreditWatch with negative implications, citing its nearly $15 billion deal to acquire mental-illness drug developer Intra-Cellular Therapies.

Welcome to Day 2 of the J.P. Morgan Healthcare Conference 2025 in San Francisco. | Welcome to Day 2 of the J.P. Morgan ...

Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tim ...